The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing - Wikidata - awgldk - TriplyDB

The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing

The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing

http://www.wikidata.org/entity/Q27687800

about

The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity Th17 Cells in Type 1 Diabetes: Role in the Pathogenesis and Regulation by Gut Microbiome Animal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside-a Comprehensive Review Biomarkers of An Autoimmune Skin Disease--Psoriasis IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans Change of paradigm: CD8+ T cells as important helper for CD4+ T cells during asthma and autoimmune encephalomyelitis A brief history of T cell help to B cells Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH 17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis T Helper Cell Subsets in Clinical Manifestations of Psoriasis Development and Function of Secondary and Tertiary Lymphoid Organs in the Small Intestine and the Colon Cancers Related to Immunodeficiencies: Update and Perspectives Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment Cytokines in psoriasis T(H)17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26 Cytokine responses in birds challenged with the human food-borne pathogen Campylobacter jejuni implies a Th17 response Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells Inaugural Symposium on Advanced Surgical Techniques in Adult Airway Reconstruction: Proceedings of the North American Airway Collaborative (NoAAC).Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3β-C/EBPβ pathway FcγRIIIa-Syk Co-signal Modulates CD4+ T-cell Response and Up-regulates Toll-like Receptor (TLR) Expression Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease Is secukinumab a safe alternative treatment for ankylosing spondylitis with Guillain Barré syndrome after anti-TNF-α treatment? Case report and literature review.The role of IL-23/Th17 pathway in patients with primary immune thrombocytopenia.Interleukin 35-Producing B Cells (i35-Breg): A New Mediator of Regulatory B-Cell Functions in CNS Autoimmune Diseases.JunB is essential for IL-23-dependent pathogenicity of Th17 cells.IL-17 induced NOTCH1 activation in oligodendrocyte progenitor cells enhances proliferation and inflammatory gene expression Enhancement of Th1/Th17 inflammation by TRIM21 in Behçet's disease.Cellular and Molecular Defects Underlying Invasive Fungal Infections-Revelations from Endemic Mycoses.Cytokine-modulating strategies and newer cytokine targets for arthritis therapy.IL-27-induced modulation of autoimmunity and its therapeutic potential.Signaling through IL-17C/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis.Elucidating new drug targets in psoriasis by gene profiling: an opportunity to be seized.Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci Secretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in Mice.C/EBPβ Promotes Immunity to Oral Candidiasis through Regulation of β-Defensins.Inborn errors in immunity: unique natural models to dissect oral immunity.Immune Interactions with Pathogenic and Commensal Fungi: A Two-Way Street COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis

P2860

Q26750673-FF0BFBB9-D8AC-410F-B899-85AD365AD7E6 Q26769612-DA7977DA-CE3E-4B02-AB93-39D59EE858F8 Q26774874-DE7AC1B0-81D7-4FF7-B9F5-4E6479B2EA45 Q26781378-CC997212-6070-4ED0-ADA9-E75323AC68E2 Q26799351-92B4ECB9-518F-4EA7-BFA0-E4C7B4C01CB8 Q26824572-515427E5-50DD-4CDB-9CC6-E1190903374A Q26825185-4AE63F6E-0136-4F77-9224-A5C08EACF50E Q26863295-29C84E25-E662-44BA-A409-A984450CB30D Q27025620-EF4302E8-70CA-49FE-AE37-C0265E746F0E Q27702597-C1E8D58B-E474-4567-A2D1-D15737A1F5E8 Q28069422-7BB86FDF-A428-4CAE-B9C0-695399DEE992 Q28069848-F7ECEDE7-F404-4B4C-AC18-B6A64E434DD8 Q28071695-66CE39BC-9F96-434F-8669-96A7248D64CB Q28074182-24786261-B9A3-4E8C-AE9B-5A39B8782D8C Q28077126-54BB2D5D-8C68-4D7A-9BF0-630FF505C4E5 Q28255491-918F3B32-B6DC-4B37-95BC-1671158D3EEA Q28264988-1EF00729-7A03-4277-BA45-0BC340FA11D7 Q28601246-061142B9-4E25-4018-B080-3C486F8570F1 Q28829881-43CC3D01-EA58-4872-892D-A20E3E22CBD3 Q30252605-47E2EF8A-A7FE-4431-A8E9-2E5D45225D74 Q30664773-8D99267F-4B79-445F-B374-D2801B2E8853 Q30698666-B0C83767-F832-41C0-B34B-47DE724115B6 Q30811549-B784DB48-1718-4793-B643-FCAB67C4CB80 Q31165527-348E67DE-617D-48C4-A440-33464B0401DB Q33419990-222074FC-1A9C-4B32-B5C0-C2DDF8A3A29E Q33694092-BEDDED02-E4C2-41E9-96C3-794458C78216 Q33766636-95A0FDAA-A1EE-40FE-A9C2-43482EE63FDE Q33766764-4E97E485-9A29-4940-806F-E9A333A2F69C Q33774072-E06020C5-30D0-43E2-82D5-84191AD90AC1 Q33843057-E20F9FF3-FBD7-4814-AFBD-11DA16DE9FBA Q34456715-E88C6DD1-D111-4DEF-A9D2-134202D27A24 Q34488727-5DBF2E2B-EC49-4235-976D-D2AD1CD6CF09 Q35301398-DEB90151-03E6-48DD-B760-8AC7843E9334 Q35561339-455E7420-351A-49F5-B0F3-7A0F481F293A Q35575687-C74617BE-73E8-43A7-A007-CEC131D9D896 Q35650359-EC182325-D7F5-48D7-903C-65920BAB7013 Q35758463-2EEEF022-BFC1-4C6D-A092-F252C064197F Q35797001-DEBC5E50-271A-4B94-9D8C-0466CE911E5A Q35847333-6288026C-8323-46ED-A0BB-DAA79D1E8FE9 Q35885484-64327A05-471F-4AFA-984C-F400D59E3BF2

P2860

The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing

http://www.wikidata.org/entity/Q27687800

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing

@ast

The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing

@en

The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing.

@nl

type

label

The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing

@ast

The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing

@en

The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing.

@nl

prefLabel

The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing

@ast

The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing

@en

The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing.

@nl

P1433

Q27687800-38CA0D20-F164-45D3-9FA0-AC1F7D2E714B

P1476

Q27687800-3090E3C9-3668-4388-9E04-386E8EE422BA

P2093

Q27687800-A5327917-4593-4816-A787-C88FCE4F7295

Q27687800-D0A0307D-0C68-4065-85F5-DBF49B23F9E5

Q27687800-F53DFD80-F227-4529-8D72-8D9872ABFAFD

Q27687800-FC06F198-CA0E-4ADC-AFB5-AD9A7578B09A

P2860

Q27687800-00E2D8E5-BAFA-46DE-AC64-842D0CCDFD68

Q27687800-01A35897-51D0-4F43-8A44-8D7CEE7F7B44

Q27687800-038498F4-10DF-4C6A-8B81-CF837A8F4D9F

Q27687800-04B8EF3D-F2C5-471A-BD8A-CEBEC6D5595C

Q27687800-05EEE6EC-C18A-4C98-9919-33E7272E7E0A

Q27687800-07420C90-877A-400A-A4D9-EE15C5B66EF1

Q27687800-074C8394-4FA0-4807-A52E-70264FCC57F1

Q27687800-08447667-03D8-4312-BD75-43B4E65C3A9F

Q27687800-0BB71F29-853C-4FA4-949F-2864E49E709C

Q27687800-0BE3CC6D-C739-436D-8949-2AE890380158

P304

Q27687800-9F29705D-CEE2-4A7B-A5E2-518BC24D03F2

P31

Q27687800-5928A7DF-93CC-492C-A79D-11E52DE57882

P3181

Q27687800-F42FA57F-70C0-4135-9911-A427D547ECB0

P356

Q27687800-B5C87ED6-2D9D-4420-A8D2-D4B70CCC4472

P433

Q27687800-AC531041-BE29-40C6-9B1C-EEEA3AA2A5C6

P478

Q27687800-85B743BA-57D2-4F4C-9AFC-B127951EE892

P577

Q27687800-A76A5921-00C1-4741-A59E-00B9AE8B6D31

P698

Q27687800-F7774810-6E90-454E-B937-7E32125D7E04

P932

Q27687800-FD5DA580-6C1A-4BC6-BAFE-74E60FB2D104

P3181

P356

P1433

Nature Reviews Immunology

P1476

The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing

@en

P2093

Abhishek V. Garg

http://www.w3.org/2001/XMLSchema#string

Daniel J. Cua

http://www.w3.org/2001/XMLSchema#string

Renu Jain

http://www.w3.org/2001/XMLSchema#string

Sarah L. Gaffen

http://www.w3.org/2001/XMLSchema#string

P2860

A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci

Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12

A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R

Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-kappaB activation

Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF)

Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1

CCAAT/enhancer-binding proteins: structure, function and regulation

The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo

MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development

P304

585-600

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

558995

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NRI3707

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25145755

http://www.w3.org/2001/XMLSchema#string

P932

4281037

http://www.w3.org/2001/XMLSchema#string